1 active not recruiting, 1 completed, 1 recruiting. 3 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
Follow Thyroid Cancer: new trials by email Literature Review of Thyroid Cancer trials Research Report on Thyroid Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors INN805 - Maligant Solid Tumor, Head & Neck Cancer | Early Phase 1 | Recruiting | FindCure Biosciences (ZhongShan) Co., Ltd. | 10 | 2026-04-20 | 2026-09-04 |
| RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers Durvalumab (Medi4736), Radioiodine (RAI) - Thyroid Cancer | Early Phase 1 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 11 | 2017-07-10 | 2026-08-11 |
| A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression Bexarotene - Thyroid Cancer | Early Phase 1 | Completed | University of Colorado, Denver | 10 | 2008-11-01 | 2014-01-17 |
Thyroid Neoplasms (3) · Aggression (1) · Breast Neoplasms (1) · Head and Neck Neoplasms (1) · Sarcoma (1)
Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Thyroid Diseases (3) · Head and Neck Neoplasms (2) · Aberrant Motor Behavior in Dementia (1) · Behavior (1) · Behavioral Symptoms (1) · Breast Diseases (1) · Neoplasms by Histologic Type (1) · Neoplasms, Connective and Soft Tissue (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1) · Social Behavior (1)
Bexarotene (1) · Iodine-131 (1) · durvalumab (1)
FindCure Biosciences (ZhongShan) Co., Ltd. (1) · Memorial Sloan Kettering Cancer Center (1) · University of Colorado, Denver (1)
United States (2) · China (1)
Alan Ho, MD, PhD (1) · Joshua Klopper, MD (1)